SANOFI CONSUMER HEALTHCARE INDIA
|
The Current P/B Ratio of SANOFI CONSUMER HEALTHCARE INDIA is 24.94.
| Share Price | ₹4,163.6 | Aug 25,2026 |
| Market Cap | ₹9,576.2 Cr | |
| Book Value | ₹384.0 Cr | Dec2025 - Standalone Results |
| Price/Book | 24.94x | Calculated as MarketCap/Book Value |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PB (Price/Book ) ratio of SANOFI CONSUMER HEALTHCARE INDIA
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹9,576.2 Cr] as on Aug 25,2026
(/) Book Value [ ₹384.0 Cr] based on Dec2025 - Standalone Results
(=) P/B Ratio [ 24.94x ]
Thus, for SANOFI CONSUMER HEALTHCARE INDIA , the investors are currently willing to pay '24.94 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of SANOFI CONSUMER HEALTHCARE INDIA !
The chart below summarizes the trend in P/B Ratio of SANOFI CONSUMER HEALTHCARE INDIA over the last five years.
Historical PB (Price/Book ) ratio chart of SANOFI CONSUMER HEALTHCARE INDIA
PB Ratio Performance Analysis for SANOFI CONSUMER HEALTHCARE INDIA
- SANOFI CONSUMER HEALTHCARE INDIA 's p/b ratio for fiscal years ending Dec2025 to Dec2023 averaged 22.92x.
- SANOFI CONSUMER HEALTHCARE INDIA 's operated at median p/b ratio of 27.11x from fiscal years ending March 2018 to 2022.
- Looking back at the last 3 fiscal years, SANOFI CONSUMER HEALTHCARE INDIA 's p/b ratio peaked in Dec2024 at 41.66x.
- SANOFI CONSUMER HEALTHCARE INDIA 's p/b ratio hit its five-year low in Dec2023 of 0x.
How does SANOFI CONSUMER HEALTHCARE INDIA 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
|---|---|---|---|
| SANOFI CONSUMER HEALTHCARE INDIA | 384.00 | 24.94 | 9,576.2 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 83,570.10 | 5.50 | 459,952.0 |
| DIVIS LABORATORIES LTD | 16,761.00 | 13.75 | 230,427.0 |
| TORRENT PHARMACEUTICALS LTD | 8,388.43 | 22.31 | 187,141.0 |
| CIPLA LTD | 34,369.40 | 3.34 | 114,715.0 |
| DR REDDYS LABORATORIES LTD | 37,742.60 | 2.63 | 99,409.9 |
| MANKIND PHARMA LTD | 16,252.60 | 6.01 | 97,756.1 |
| LUPIN LTD | 22,384.10 | 4.44 | 99,448.6 |
| ZYDUS LIFESCIENCES LTD | 27,111.40 | 4.16 | 112,718.0 |
| AUROBINDO PHARMA LTD | 37,891.00 | 2.43 | 92,247.5 |
| LAURUS LABS LTD | 5,275.08 | 19.10 | 100,768.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs SANOFI CONSUMER HEALTHCARE INDIA 's P/B Ratio
| Top 10 Industry Peers | PB Ratio |
|---|---|
| Min industry PB | 2.43x |
| Max industry PB | 24.94x |
| Median industry PB | 5.50x |
| Average industry PB | 9.88x |
You may also like the below Video Courses